BioCardia Depreciation & Amortization Growth & History (BCDA)
BioCardia's depreciation and amortization was $24,000 for fiscal 2025.
View full BioCardia company overviewBioCardia annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24,000 | −$43,000 | −64.18% |
| 2024 | 2024-12-31 | $67,000 | −$17,000 | −20.24% |
| 2023 | 2023-12-31 | $84,000 | $2,000 | +2.44% |
| 2022 | 2022-12-31 | $82,000 | $22,000 | +36.67% |
| 2021 | 2021-12-31 | $60,000 | −$8,000 | −11.76% |
| 2020 | 2020-12-31 | $68,000 | −$43,000 | −38.74% |
| 2019 | 2019-12-31 | $111,000 | $23,000 | +26.14% |
| 2018 | 2018-12-31 | $88,000 | $10,000 | +12.82% |
| 2017 | 2017-12-31 | $78,000 | $39,000 | +100.00% |
| 2016 | 2016-12-31 | $39,000 | −$8,000 | −17.02% |
| 2015 | 2015-12-31 | $47,000 | — | — |
| 2011 | 2011-12-31 | $0 | −$967,000 | — |
| 2010 | 2010-12-31 | $967,000 | — | — |
BioCardia quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3,000 | −$2,000 | −40.00% |
| Q1 2026 | 2026-03-31 | $3,000 | −$9,000 | −75.00% |
| Q4 2025 | 2025-12-31 | $3,000 | — | — |
| Q3 2025 | 2025-09-30 | $4,000 | −$12,000 | −75.00% |
| Q2 2025 | 2025-06-30 | $5,000 | −$12,000 | −70.59% |
| Q1 2025 | 2025-03-31 | $12,000 | −$7,000 | −36.84% |
| Q3 2024 | 2024-09-30 | $16,000 | −$5,000 | −23.81% |
| Q2 2024 | 2024-06-30 | $17,000 | −$4,000 | −19.05% |
| Q1 2024 | 2024-03-31 | $19,000 | −$3,000 | −13.64% |
| Q3 2023 | 2023-09-30 | $21,000 | −$8,000 | −27.59% |
| Q2 2023 | 2023-06-30 | $21,000 | $5,000 | +31.25% |
| Q1 2023 | 2023-03-31 | $22,000 | $6,000 | +37.50% |
| Q3 2022 | 2022-09-30 | $29,000 | $14,000 | +93.33% |
| Q2 2022 | 2022-06-30 | $16,000 | $0 | 0.00% |
| Q1 2022 | 2022-03-31 | $16,000 | $2,000 | +14.29% |
| Q3 2021 | 2021-09-30 | $15,000 | −$1,000 | −6.25% |
| Q2 2021 | 2021-06-30 | $16,000 | $2,000 | +14.29% |
| Q1 2021 | 2021-03-31 | $14,000 | −$8,000 | −36.36% |
| Q3 2020 | 2020-09-30 | $16,000 | −$13,000 | −44.83% |
| Q2 2020 | 2020-06-30 | $14,000 | −$12,000 | −46.15% |
| Q1 2020 · Mar 31 | 2020-03-31 | $22,000 | −$1,000 | −4.35% |
| Q3 2019 | 2019-09-30 | $29,000 | $7,000 | +31.82% |
| Q2 2019 | 2019-06-30 | $26,000 | $4,000 | +18.18% |
| Q1 2019 | 2019-03-31 | $23,000 | $1,000 | +4.55% |
| Q3 2018 | 2018-09-30 | $22,000 | $1,000 | +4.76% |
| Q2 2018 | 2018-06-30 | $22,000 | −$1,000 | −4.35% |
| Q1 2018 | 2018-03-31 | $22,000 | $9,000 | +69.23% |
| Q3 2017 | 2017-09-30 | $21,000 | $12,000 | +133.33% |
| Q2 2017 | 2017-06-30 | $23,000 | $12,000 | +109.09% |
| Q1 2017 | 2017-03-31 | $13,000 | $3,000 | +30.00% |
| Q3 2016 | 2016-09-30 | $9,000 | — | — |
| Q2 2016 | 2016-06-30 | $11,000 | — | — |
| Q1 2016 | 2016-03-31 | $10,000 | — | — |
| Q3 2011 | 2011-09-30 | $0 | −$280,000 | — |
| Q3 2010 | 2010-09-30 | $280,000 | — | — |
BioCardia depreciation and amortization trends
Over the last five fiscal years, BioCardia's depreciation and amortization decreased from $68,000 to $24,000, a change of −$44,000. The latest reported quarter, Q2 2026, shows $3,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioCardia source filings ↗